Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432
Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma
Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
Current vaccination strategies for prostate cancer
Proving the principle: dendritic cell-based vaccines in urogenital cancers
Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients
Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
Current immunotherapeutic approaches in pancreatic cancer
Immunotherapy in human glioblastoma
Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia
Apoptin enhances the oncolytic properties of Newcastle disease virus
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
Immunotherapy for prostate cancer: biology and therapeutic approaches
Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
Treatment of high-grade glioma in children and adolescents